TxCell: Financial Information for the 3rd Quarter of 2016 – Business Wire (press release)

TxCell: Financial Information for the 3rd Quarter of 2016 – Business Wire (press release)

TxCell: Financial Information for the 3rd Quarter of 2016
Business Wire (press release)
TxCell SA (Paris:TXCL) (FR0010127662 – TXCL), a biotechnology company developing innovative, personalized cellular immunotherapies using regulatory T cells (Treg) to treat severe chronic inflammatory and autoimmune diseases, today reports its …

TxCell: Financial Information for the 3rd Quarter of 2016 – Business Wire (press release)